Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)

May 9, 2023 updated by: University of Kansas Medical Center

Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)

The purpose of this study is to compare two methods for managing obesity in rural primary care patients. The first method includes quarterly 1:1 meetings with the participant and their primary care provider and the second includes a group lifestyle intervention over Zoom paired with quarterly team meetings with the participant, their primary care provider and their lifestyle coach, the coach joining via Zoom. Investigators will evaluate which method is best at helping participants lose weight over 18 months.

Study Overview

Detailed Description

Obesity increases risk for 13 types of cancer and now affects over 40% of the U.S. adult population, with even higher prevalence among rural Americans. Rural residents often lack access to weight control programs and food and physical activity resources that promote healthy lifestyles, especially in small or remote rural areas. It is important for obesity treatment to be offered in rural primary care, yet local resources are often lacking. Medical management by a primary care provider (PCP) during behavioral weight loss is essential to address co-morbid medical conditions, evaluate obesogenic medications, and explore options for guideline-recommended pharmacotherapy and surgical treatment. This study is designed to enhance sustainable access to obesity treatment in rural communities by offering education to local providers on obesity management and integrating team-based care into an obesity treatment model through telemedicine.

The two methods of obesity treatment to be studied are:

  • Local Care + Arm: Quarterly clinic visits with the participants and their local primary care provider
  • Team Care Arm: An intensive group lifestyle intervention offered by a lifestyle coach via Zoom, paired with quarterly clinic visits with the participant, their local primary care provider and the lifestyle coach, the coach joining via telemedicine.

Participants will be in the study about 18 months. Participants in the Local Care + arm will be asked to complete 4 data collection visits and 6 quarterly clinic visits. Participants in the Team Care arm will be asked to complete 4 data collection visits, 30 counseling sessions and 6 quarterly clinic visits.

Study Type

Interventional

Enrollment (Anticipated)

560

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Missouri
      • Kansas City, Missouri, United States, 66160
        • Recruiting
        • University of Kansas Medical Center
        • Contact:
        • Principal Investigator:
          • Christie Befort, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • BMI: >= 30 kg/m2
  • Rural resident
  • English speaking
  • Physician clearance to participate
  • Able to walk without assistance
  • Seen at least once in their primary care clinic within the past year
  • Internet access or smart phone (to access smart scale for weight measurement)

Exclusion Criteria:

  • History of myocardial infarction within last six months
  • History of stroke within last six months
  • History of new cancer diagnosis within last six months
  • History of bariatric surgery within the last two years
  • Pregnancy within last 6 months or planned within the next 18 months
  • Currently breastfeeding
  • End stage renal disease, currently on dialysis, or anticipated dialysis or renal transplant within the next 18 months
  • End stage liver disease, or anticipated liver transplant within the next 18 months
  • Currently enrolled or planning to enroll in another study where weight loss is targeted or weight fluctuation is expected
  • Currently planning to move outside of current provider area, or leave primary care clinic within the next 18 months
  • Another household member is already participating in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Local Care + Model
Quarterly clinic visits with a local primary care provider

Local primary care providers receive training in medical management of obesity prior to the start of the participant intervention.

Participants receive 6 quarterly clinic visits with their local primary care provider focused on medical management of obesity.

Active Comparator: Team Care Model
An intensive group lifestyle intervention led by a lifestyle coach via Zoom, paired with quarterly clinic visits with a local primary care provider and the lifestyle coach, the coach joining via telemedicine.

Local primary care providers receive training in medical management of obesity prior to the start of the participant intervention.

Participants receive an intensive 18-month group lifestyle intervention (30 total sessions) led by a study lifestyle coach via Zoom, and 6 quarterly 1:1 visits via Zoom with their lifestyle coach. Participants also receive 6 quarterly clinic visits with their local primary care provider; the study lifestyle coach joins the visits via telemedicine. All three parties may meet via telemedicine if needed. The group lifestyle intervention is led by obesity treatment specialists with relevant graduate training and experience.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent weight loss at 18 months
Time Frame: 18 months
Mean percent weight loss at 18 months; unadjusted
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent weight loss at 6 months
Time Frame: 6 months
Mean percent weight loss at 6 months; unadjusted
6 months
Percent weight loss at 12 months
Time Frame: 12 months
Mean percent weight loss at 12 months; unadjusted
12 months
Weight loss (kg) at 6 months
Time Frame: 6 months
Mean weight loss (kg) at 6 months; unadjusted
6 months
Weight loss (kg) at 12 months
Time Frame: 12 months
Mean weight loss (kg) at 12 months; unadjusted
12 months
Weight loss (kg) at 18 months
Time Frame: 18 months
Mean weight loss (kg) at 18 months; unadjusted
18 months
Proportion achieving ≥5% weight loss at 6 months
Time Frame: 6 months
Proportion achieving ≥5% weight loss at 6 months; unadjusted
6 months
Proportion achieving ≥5% weight loss at 12 months
Time Frame: 12 months
Proportion achieving ≥5% weight loss at 12 months; unadjusted
12 months
Proportion achieving ≥5% weight loss at 18 months
Time Frame: 18 months
Proportion achieving ≥5% weight loss at 18 months; unadjusted
18 months
Proportion achieving ≥10% weight loss at 6 months
Time Frame: 6 months
Proportion achieving ≥10% weight loss at 6 months; unadjusted
6 months
Proportion achieving ≥10% weight loss at 12 months
Time Frame: 12 months
Proportion achieving ≥10% weight loss at 12 months; unadjusted
12 months
Proportion achieving ≥10% weight loss at 18 months
Time Frame: 18 months
Proportion achieving ≥10% weight loss at 18 months; unadjusted
18 months
Change in diet quality at 6 months
Time Frame: Baseline and 6 months
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 6 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
Baseline and 6 months
Change in diet quality at 12 months
Time Frame: Baseline and 12 months
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 12 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
Baseline and 12 months
Change in diet quality at 18 months
Time Frame: Baseline and 18 months
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 18 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
Baseline and 18 months
Change in physical activity at 6 months
Time Frame: Baseline and 6 months
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 6 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
Baseline and 6 months
Change in physical activity at 12 months
Time Frame: Baseline and 12 months
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 12 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
Baseline and 12 months
Change in physical activity at 18 months
Time Frame: Baseline and 18 months
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 18 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
Baseline and 18 months
Change in physical quality of life at 6 months
Time Frame: Baseline and 6 months
Mean change in physical quality of life, measured by SF-12 at 6 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 6 months
Change in physical quality of life at 12 months
Time Frame: Baseline and 12 months
Mean change in physical quality of life, measured by SF-12 at 12 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 12 months
Change in physical quality of life at 18 months
Time Frame: Baseline and 18 months
Mean change in physical quality of life, measured by SF-12 at 18 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 18 months
Change in mental quality of life at 6 months
Time Frame: Baseline and 6 months
Mean change in mental quality of life, measured by SF-12 at 6 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 6 months
Change in mental quality of life at 12 months
Time Frame: Baseline and 12 months
Mean change in mental quality of life, measured by SF-12 at 12 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 12 months
Change in mental quality of life at 18 months
Time Frame: Baseline and 18 months
Mean change in mental quality of life, measured by SF-12 at 18 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning.
Baseline and 18 months
Change in weight-related quality of life at 6 months
Time Frame: Baseline and 6 months
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 6 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life.
Baseline and 6 months
Change in weight-related quality of life at 12 months
Time Frame: Baseline and 12 months
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 12 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life.
Baseline and 12 months
Change in weight-related quality of life at 18 months
Time Frame: Baseline and 18 months
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 18 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life.
Baseline and 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christie Befort, PhD, University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2023

Primary Completion (Anticipated)

April 1, 2026

Study Completion (Anticipated)

April 1, 2026

Study Registration Dates

First Submitted

December 29, 2022

First Submitted That Met QC Criteria

January 24, 2023

First Posted (Actual)

February 2, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00147574
  • 1R01CA268034-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A clean, de-identified copy of the final dataset will be created within 30 days of publication of the primary outcome paper. The data will be made available to researchers upon email request to the Principal Investigator. We will convert date of birth to age, and other identifiers (e.g, address, zip code, state) will be removed. We will make the data and associated documentation available to users under a data-sharing agreement that provides for: (1) a commitment to use the data solely for research purposes and to not identify individual participants during use or publication; (2) a commitment to secure the data using appropriate computer technology upon receipt; and (3) a commitment to destroy or return the data to KUMC after analyses are completed. Data will be saved as SAS or SPSS files, and provided to requesters via KUMC's Secure File Transfer service. A copy of our analytic code used to generate our primary outcomes paper(s) will be made available on request in the same fashion.

IPD Sharing Time Frame

Within 30 days of publication of the primary outcome paper

IPD Sharing Access Criteria

upon email request to the Principal Investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Local Care + Model

3
Subscribe